Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection

被引:101
作者
Satoskar, AR [1 ]
Bozza, M [1 ]
Sosa, MR [1 ]
Lin, GS [1 ]
David, JR [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1128/IAI.69.2.906-911.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the role of endogenous migration-inhibitory factor (MIF) in the development of protective immunity against cutaneous leishmaniasis, we analyzed the course of cutaneous Leishmania major infection in MIF gene deficient mice (MIF-/-) and wild-type (MIF+/+) mice. Following cutaneous L. major infection, MIF-/- mice were susceptible to disease and developed significantly larger lesions and greater parasite burdens than MIF+/+ mice, Interestingly, antigen-stimulated lymph node cells from MIF-/- mice produced more interleukin-4 (IL-4) and gamma interferon (IFN-gamma) than those from MIF+/+ mice, although the differences were statistically not significant. IFN-gamma -activated resting peritoneal macrophages front MIF-/- mice showed impaired macrophage leishmanicidal activity and produced significantly lower levels of nitric oxide and superoxide in vitro. The macrophages from MIF-/- mice, however, produced much more IL-6 than macrophages from wild-type mice. These findings demonstrate that endogenous MIF plays an important role in the development of protective immunity against L. major in vivo. Furthermore, they indicate that the susceptibility of MIF-/- mice to L, major infection is due to impaired macrophage leishmanicidal activity rather than dysregulation of Th1 and Th2 responses.
引用
收藏
页码:906 / 911
页数:6
相关论文
共 23 条
[1]  
Alexander J, 1999, J CELL SCI, V112, P2993
[2]   An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].
Bacher, M ;
Metz, CN ;
Calandra, T ;
Mayer, K ;
Chesney, J ;
Lohoff, M ;
Gemsa, D ;
Donnelly, T ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854
[3]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[4]   Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346
[5]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[6]   ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS [J].
GREEN, LC ;
WAGNER, DA ;
GLOGOWSKI, J ;
SKIPPER, PL ;
WISHNOK, JS ;
TANNENBAUM, SR .
ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) :131-138
[7]  
HATZIGEORGIOU DE, 1993, J IMMUNOL, V151, P3682
[8]   PRODUCTION OF INTERFERON-GAMMA, INTERLEUKIN-2, INTERLEUKIN-4, AND INTERLEUKIN-10 BY CD4+ LYMPHOCYTES INVIVO DURING HEALING AND PROGRESSIVE MURINE LEISHMANIASIS [J].
HEINZEL, FP ;
SADICK, MD ;
MUTHA, SS ;
LOCKSLEY, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7011-7015
[9]   A proinflammatory cytokine inhibits p53 tumor suppressor activity [J].
Hudson, JD ;
Shoaibi, MA ;
Maestro, R ;
Carnero, A ;
Hannon, GJ ;
Beach, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1375-1382
[10]  
Jüttner S, 1998, J IMMUNOL, V161, P2383